Therefore, we combined a bench-top bile processing method (Figure 1b) with a microfluidic system (Figure 1c) to screen human bile for the presence of the CCA biomarkers EpCAM, CK7 and CK17. This evidence concerns the gene EPCAM and cholangiocarcinoma.